Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras.
Pauli VähämurtoSusanna MannistoMarjukka PollariMarja-Liisa Karjalainen-LindsbergAntti Aarni MäkitieSirpa LeppaPublished in: European journal of haematology (2019)
Patients with SNT-DLBCL benefit from rituximab and CNS-directed chemotherapy.